Skip to content
CVS’s fourth quarter results beat expectations as Covid testing boosts overall store sales

A teenage girl receives her Pfizer Covid-19 booster at a CVS pharmacy in New York City on January 20, 2022.

Adam Jeffery | CNBC

CVS Health said Wednesday that demand for at-home Covid tests and recalls boosted overall store sales, helping the company beat expectations for fourth-quarter earnings.

Shares of the drugstore chain and health insurer fell more than 2% in premarket trading.

Here’s what the company reported for the three months ended Dec. 31, compared to what analysts expected, based on an analyst survey by Refinitiv:

  • Earnings per share: $1.98 adjusted vs $1.93 forecast
  • Revenue: $76.60 billion vs. $75.67 billion expected

CVS reported fiscal fourth-quarter net income of $1.31 billion, or 99 cents per share, from $973 million, or 74 cents per share, a year earlier.

The company said its net income from continuing operations was 98 cents. But it earned $1.98 per share, after adjustments, which was better than the $1.93 per share expected by analysts polled by Refinitiv.

Total revenue for the period rose to $76.60 billion from $69.55 billion a year earlier, surpassing expectations of $75.67 billion.

Shares of CVS are up 51% in the past 12 months and hit a 52-week high on Tuesday. Shares closed Tuesday at $110.83, up 1.3%. The market value of the company is $146.30 billion.

cnbc-health care

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.